Arkolith/Insider Trading/ENZN/Form 4

Read Randolph C

DirectorENZON PHARMACEUTICALS, INC. (ENZN) · full profile →Form 4 · filed Jun 16, 2023
Net Buying
Open-Market Buys
$14K
Open-Market Sells
$0
Net Open-Market Flow
$14K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2023Buy(P)85K$0.14$12K200K
Jun 14, 2023Buy(P)15K$0.13$2K115K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-072222) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML